Albiglutide, a glucagon-like peptide-1 (GLP-1) mimetic, is a long-actingGLP-1receptor agonist. Albiglutide significantly reduces glycosylated hemoglobin (A1C). Albiglutide can be used for type 2 diabetes (T2D) research. Albiglutide is generated by the genetic fusion of a DPP-4-resistantGLP-1dimer to human albumin^[1][2][3].

3283.60

C₁₄₈H₂₂₄N₄₀O₄₅

782500-75-8

His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2

HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.